- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 192
SutroVax diagnoses $85m series C
Pivotal BioVenture Partners and Roche have both returned to back a series C round for SutroVax, which has also added TPG, Medicxi and Foresite Capital to its shareholders.
Jun 8, 2018M17 ditches IPO at the last minute
M17 Entertainment, backed by MCN, Yahoo Japan and LeSports, was expected to float on the New York Stock Exchange yesterday but still has not begun trading.
Jun 8, 2018Ant Financial pushes series C to $14bn
The round was already the largest ever at the previously reported $10bn mark but has been revealed to stand even taller with an additional $4bn.
Jun 8, 2018EPropulsion stares into Beyond for $10m
Marine product maker EPropulsion, which was founded by a HKUST graduate, will soon launch a 4K resolution subsea drone camera.
Jun 8, 2018AMC Entertainment lets Abry onto Screenvision
Abry has acquired cinema marketing distributor Screenvision for $380m in a deal which bagged AMC Entertainment a $45m return.
Jun 7, 2018Camp4 discovers Kraft in its $30m A round
Camp4 has attracted capital from investors such as Kraft Group to continue development of its drug discovery platform based on work at MIT and Harvard Medical School.
Jun 7, 2018Susquehanna unloads GlobalTranz
Freight brokerage GlobalTranz will be acquired by private equity firm Jordan Company after raising $50m from two rounds in 2014 and 2011.
Jun 7, 2018Verity reaches series A heights
Airbus Ventures and Sony Innovation Fund have taken part in an $18m series A round for Verity Studios, which produces indoor drone technology.
Jun 7, 2018Investors remain loyal to Stocard
Stocard, the developer of a mobile loyalty app backed by Cewe, has secured $20m from investors including Engelhorn.
Jun 7, 2018HJB imparts series B+ knowledge
Taikang Life and Lilly Asia Ventures, which backed the initial $59.7m series B round last year, have also contributed to a $35m series B+ round of Hangzhou Just Biotherapeutics.
Jun 7, 2018About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


